PITRM1
protein-codingpitrilysin metallopeptidase 1, the group of M16 metallopeptidases
Gene summary
The protein encoded by this gene is an ATP-dependent metalloprotease that degrades post-cleavage mitochondrial transit peptides. The encoded protein binds zinc and can also degrade amyloid beta A4 protein, suggesting a possible role in Alzheimer's disease. [provided by RefSeq, Dec 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~35.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030318
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0030318
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0030318
Submitter: Illumina
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PITRM1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014889.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 103 | 1 | 109 | ||
| missense | 1 | 245 | 43 | 8 | 297 | |
| nonsense | 1 | 3 | 1 | 5 | ||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 5 | 1 | 8 | |
| splice donor/acceptor (+/-2bp) | 8 | 8 | ||||
| Total | 1 | 3 | 266 | 148 | 9 | 427 |
Highest pathogenic variant AF is 0.000043995213
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055704.2 | 27 | MANE Select | |
| Ensembl | ENSP00000224949.4 | 27 | MANE Select | |
| RefSeq | NP_001229236.1 | 27 | Standard | |
| RefSeq | NP_001229238.1 | 24 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- proteolysis
- protein targeting to mitochondrion
- protein processing
- positive regulation of catalytic activity
Molecular Function
- metalloendopeptidase activity
- enzyme activator activity
- metallopeptidase activity
- zinc ion binding
Cellular Component
- mitochondrion
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000380989
- Coding exons
- 27
- Length
- 35084
- Individuals with no LoFs
- 124464
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 184
- Defined
- 124648
- p
- 0.000738
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.837 | 653 | 596 | 1.10 | 0.0000349 | 6808 |
| Missense (PolyPhen) | 199 | 202.42 | 0.98308 | 2350 | ||
| Synonymous | -2.68 | 302 | 248 | 1.22 | 0.0000172 | 1926 |
| Loss of Function | 1.93 | 40 | 55.5 | 0.721 | 0.00000272 | 657 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0024 | 0.0024 | notable |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00090 | 0.00089 | rare |
| Finnish | 0.00033 | 0.00032 | rare |
| European (Non-Finnish) | 0.00083 | 0.00082 | rare |
| South Asian | 0.00073 | 0.00072 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Metalloendopeptidase of the mitochondrial matrix that functions in peptide cleavage and degradation rather than in protein processing (PubMed:10360838, PubMed:16849325, PubMed:19196155, PubMed:24931469). Has an ATP-independent activity (PubMed:16849325). Specifically cleaves peptides in the range of 5 to 65 residues (PubMed:19196155). Shows a preference for cleavage after small polar residues and before basic residues, but without any positional preference (PubMed:10360838, PubMed:19196155, PubMed:24931469). Degrades the transit peptides of mitochondrial proteins after their cleavage (PubMed:19196155). Also degrades other unstructured peptides (PubMed:19196155). It is also able to degrade amyloid-beta protein 40, one of the peptides produced by APP processing, when it accumulates in mitochondrion (PubMed:16849325, PubMed:24931469). It is a highly efficient protease, at least toward amyloid-beta protein 40 (PubMed:24931469). Cleaves that peptide at a specific position and is probably not processive, releasing digested peptides intermediates that can be further cleaved subsequently (PubMed:24931469). {ECO:0000269|PubMed:10360838, ECO:0000269|PubMed:16849325, ECO:0000269|PubMed:19196155, ECO:0000269|PubMed:24931469}.;
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- LoFtool
- 0.982
- RVIS EVS
- 3.22
- RVIS percentile EVS
- 99.36
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Indispensability pred.
- E
- Indispensability score
- 0.655
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |